Some vaccine doses kept too cold, Pfizer having manufacturing issues, U.S. officials say

 

 

 

The first days of Pfizer Inc’s COVID-19 vaccine rollout have seen unexpected hitches including some vaccines being stored at excessively cold temperatures and Pfizer reporting potential challenges in its vaccine production, U.S. officials said on a Wednesday press call.

At least two trays of COVID-19 vaccine doses delivered in California needed to be replaced after their storage temperatures dipped below minus 80 Celsius (minus 112 Fahrenheit), U.S. Army General Gustave Perna said on the call. Pfizer’s vaccines, made with partner BioNTech SE, are supposed to be kept at around minus 70C.

Officials are investigating whether storing the vaccines at ex…

Keep on reading: Some vaccine doses kept too cold, Pfizer having manufacturing issues, U.S. officials say

Must Read

BSP seen unlikely to touch rates this year

0
The Philippine central bank would probably pause monetary easing this year until previous rate cuts lead to substantial credit growth, according to Standard Chartered...